Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Hauptman, D. Glavač (2017)
Colorectal Cancer Blood-Based BiomarkersGastroenterology Research and Practice, 2017
A. Harris (2002)
Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2
R. Matsumoto, M. Tsuda, Lei Wang, N. Maishi, T. Abe, Taichi Kimura, M. Tanino, H. Nishihara, K. Hida, Y. Ohba, N. Shinohara, K. Nonomura, S. Tanaka (2015)
Adaptor protein CRK induces epithelial–mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loopCancer Science, 106
S. Toffoli, C. Michiels (2008)
Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumoursThe FEBS Journal, 275
M. Uemura, Hirofumi Yamamoto, I. Takemasa, K. Mimori, Hideyuki Hemmi, T. Mizushima, M. Ikeda, M. Sekimoto, N. Matsuura, Y. Doki, M. Mori (2010)
Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor CellsClinical Cancer Research, 16
Sophie Beyer, M. Kristensen, Kim Jensen, J. Johansen, P. Staller (2008)
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF*Journal of Biological Chemistry, 283
H. Merikallio, T. T, P. Pääkkö, R. Mäkitaro, R. Kaarteenaho, Siri Lehtonen, S. Salo, T. Salo, T. Harju, Y. Soini (2014)
Slug is associated with poor survival in squamous cell carcinoma of the lung.International journal of clinical and experimental pathology, 7 9
D. Cao, M. Hou, Y. Guan, M. Jiang, Yu Yang, H. Gou (2009)
Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implicationsBMC Cancer, 9
Chloe-Anne Martinez, B. Kerr, C. Jin, P. Cistulli, Kristina Cook (2019)
Obstructive Sleep Apnea Activates HIF-1 in a Hypoxia Dose-Dependent Manner in HCT116 Colorectal Carcinoma CellsInternational Journal of Molecular Sciences, 20
A. Zygulska, P. Pierzchalski (2022)
Novel Diagnostic Biomarkers in Colorectal CancerInternational Journal of Molecular Sciences, 23
A. Sar, D. Ponjevic, Mo Nguyen, A. Box, D. Demetrick (2009)
Identification and characterization of demethylase JMJD1A as a gene upregulated in the human cellular response to hypoxiaCell and Tissue Research, 337
H. Sung, J. Ferlay, R. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray (2021)
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 71
V. Bhaskara, Indra Mohanam, J. Rao, S. Mohanam (2012)
Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma CellsPLoS ONE, 7
A. Krieg, E. Rankin, D. Chan, O. Razorenova, Sully Fernandez, A. Giaccia (2009)
Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1α Enhances Hypoxic Gene Expression and Tumor GrowthMolecular and Cellular Biology, 30
Yang Shi, J. Whetstine (2007)
Dynamic regulation of histone lysine methylation by demethylases.Molecular cell, 25 1
Fei Zhao, C. Qin (2019)
EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3.European review for medical and pharmacological sciences, 23 3
Hai-yan Yang, Zhenguo Liu, C. Yuan, Yunfei Zhao, Lei Wang, Jiong Hu, D. Xie, Liwei Wang, Donghui Chen (2015)
Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.International journal of clinical and experimental pathology, 8 9
S. Wellmann, M. Bettkober, A. Zelmer, K. Seeger, M. Faigle, H. Eltzschig, C. Bührer (2008)
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1.Biochemical and biophysical research communications, 372 4
I. Song, Kyu-rae Kim, S. Lim, Seok-Hyung Kim, C. Sung (2018)
Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.Pathology, research and practice, 214 10
Hanna Suikki, P. Kujala, T. Tammela, W. Weerden, R. Vessella, T. Visakorpi (2010)
Genetic alterations and changes in expression of histone demethylases in prostate cancerThe Prostate, 70
Patrick Pollard, Christoph Loenarz, D. Mole, M. McDonough, J. Gleadle, C. Schofield, P. Ratcliffe (2008)
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha.The Biochemical journal, 416 3
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
Kesong Peng, Guoqiang Su, J. Ji, Xiaojiao Yang, Mengmeng Miao, Pingli Mo, Ming Li, Jianming Xu, Wengang Li, Chundong Yu (2018)
Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signalingThe Journal of Biological Chemistry, 293
ABSTRACTColorectal cancer (CRC) is one of the leading causes of cancer-linked deaths globally. The determination of biomarkers is important in the prognosis and treatment of CRC. Previous studies emphasized the relationship between hypoxia and CRC in humans, and there is strong evidence that this process is strongly related to HIF-1. KDM3A is a histone demethylase that could directly bind to HIF-1α, a subunit of HIF-1. This study aimed to reveal whether the expression level of the KDM3A gene could be used as a predictor of CRC. The expression levels of HIF-1α, KDM3A, and Epithelial-Mesenchymal Transition (EMT) genes were evaluated by qRT-PCR in leukocyte samples of 50 CRC patients in different stages and 50 healthy controls. HIF-1α and KDM3A expression levels were significantly higher in the CRC group, compared to the controls. Slug and ZEB-1 genes, the mesenchymal markers, showed the same significance pattern between groups. We acquired 0.664 AUC with 54% sensitivity and 85.4% specificity for separating controls from CRC patients by using the KDM3A expression levels in ROC analysis. This data support that KDM3A could be a novel supplementary biomarker in diagnosis of CRC, which could be noninvasively detected in circulation.
Balkan Journal of Medical Genetics – de Gruyter
Published: Dec 1, 2022
Keywords: biomarker; colorectal cancer; KDM3A; qRT-PCR
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.